Management of Venous Thromboembolism in Morbid Obesity With Rivaroxaban or Warfarin
Sign Up to like & getrecommendations! Published in 2022 at "Annals of Pharmacotherapy"
DOI: 10.1177/10600280221089008
Abstract: Background Rivaroxaban is a first-line option for the management of venous thromboembolism (VTE). However, limited data are available regarding its effectiveness in morbidly obese patients. Objective To evaluate rates of thrombosis and bleeding in morbidly… read more here.
Keywords: management venous; receiving rivaroxaban; venous thromboembolism; rivaroxaban warfarin ... See more keywords